Edit
Braeburn Pharmaceuticals
https://www.braeburnpharmaceuticals.com/Last activity: 25.06.2024
Probably Closed
Long-acting therapies for opioid use disorders.
Princeton, NJ
Princeton, NJ
Total raised: $110M
Investors 1
Date | Name | Website |
- | New Leaf V... | nlvpartner... |
Funding Rounds 1
Date | Series | Amount | Investors |
11.01.2018 | - | $110M | RA Capital... |
Mentions in press and media 9
Date | Title | Description |
25.06.2024 | New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl | New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl Tue, Jun 25, 2024 17:00 CET Report this content Lund, Sweden — 25 June 2024 — Camurus (NASD... |
22.01.2018 | FDA slaps down Braeburn on opioid addiction drug, putting Indivior and Alkermes in strong position | One of the frontrunners in the rush to get new opioid addiction treatments to the market has just hit a roadblock. Just days before its PDUFA date, Braeburn Pharmaceuticals got a complete response letter from the FDA in li... |
12.01.2018 | Term Sheet — Friday, January 12 | CUDDLE PUDDLES Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop Last night, Axios reported that one of these parties was held at venture capitalist Steve Jurvetson’s home. The party fol... |
11.01.2018 | Braeburn Pharmaceuticals Nabs $110M | PRINCETON, N.J., Braeburn Pharmaceuticals, (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. >> Click here for more funding data on Braeburn ... |
11.01.2018 | RA Capital Joins $110M Funding for Braeburn Pharmaceuticals | Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Cap... |
11.01.2018 | Rock Springs Capital Joins $110M Funding for Braeburn Pharmaceuticals | Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Cap... |
11.01.2018 | Braeburn Pharmaceuticals Completes $110M Mezzanine Round of Financing | Braeburn Pharmaceuticals, Inc., a Princeton, N.J.-based pharmaceutical company, completed a $110m mezzanine round of financing. The round was led by Wellington Capital Management with participation from new investors Avista Capital Partners... |
10.01.2018 | Braeburn Announces Completion of $110 Million Financing | Princeton, N.J.— January 10, 2018 — Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating... |
04.01.2017 | Term Sheet — Wednesday, January 4 | DELL-EMC, NYC EXITS, HYPEMOBILES Hello from Las Vegas, where I’m riding in cars with robots and hunting down the most ridiculous “smart” items CES has to offer. (Current front-runners: a smart mattress and a smart hairbrush.) Paid Content S... |